Phase II trial evaluating the efficacy of sorafenib (BAY 43-9006) and correlating early fluorodeoxyglucose positron emission tomography-CT response to outcome in patients with recurrent and/or metastatic head and neck cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phase II trial evaluating the efficacy of sorafenib (BAY 43-9006) and correlating early fluorodeoxyglucose positron emission tomography-CT response to outcome in patients with recurrent and/or metastatic head and neck cancer
Authors
Keywords
-
Journal
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
Volume 38, Issue 3, Pages 347-354
Publisher
Wiley
Online
2014-10-21
DOI
10.1002/hed.23898
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of Positron Emission Tomography-Computed Tomography in Head and Neck Cancer
- (2017) Emma C. Cashman et al. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY
- Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course
- (2012) Daiki Ueno et al. BMC CANCER
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation
- (2011) E. P. Hui et al. ANNALS OF ONCOLOGY
- Serial FDG–PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy
- (2011) A. Hendlisz et al. ANNALS OF ONCOLOGY
- Modern treatment for nasopharyngeal carcinoma: current status and prospects
- (2011) Sylvie Rottey et al. CURRENT OPINION IN ONCOLOGY
- Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis
- (2011) Tejpal Gupta et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Phase II Evaluation of Sorafenib in Advanced and Metastatic Squamous Cell Carcinoma of the Head and Neck: Southwest Oncology Group Study S0420
- (2010) Stephen K. Williamson et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment for metastatic nasopharyngeal carcinoma
- (2010) Y. Bensouda et al. European Annals of Otorhinolaryngology-Head and Neck Diseases
- Phase II study of sunitinib malate in head and neck squamous cell carcinoma
- (2009) Nicholas W. Choong et al. INVESTIGATIONAL NEW DRUGS
- Phase II Study of Sunitinib in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: GORTEC 2006-01
- (2009) Jean-Pascal H. Machiels et al. JOURNAL OF CLINICAL ONCOLOGY
- Monitoring Predominantly Cytostatic Treatment Response with 18F-FDG PET
- (2009) K. B. Contractor et al. JOURNAL OF NUCLEAR MEDICINE
- Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials
- (2009) Youjin Je et al. LANCET ONCOLOGY
- Hepatic Metastases of Gastric Adenocarcinoma Showing Metabolic Remission on FDG-PET Despite an Increase in Size on CT
- (2009) So Young Yoon et al. Cancer Research and Treatment
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent Advances in Head and Neck Cancer
- (2008) Robert I. Haddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
- (2008) Jan B. Vermorken et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now